NCT02338128View on ClinicalTrials.gov

The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients

CompletedOBSERVATIONAL
Enrollment

50

Participants

Timeline

Start Date

January 31, 2015

Primary Completion Date

January 31, 2018

Study Completion Date

January 31, 2018

Conditions
Disorders Associated With Peritoneal DialysisHyperuricemia
Trial Locations (1)

200072

Department of Nephrology & Rheumatology, Shanghai Tenth People's Hospital, Shanghai

All Listed Sponsors
lead

Shanghai 10th People's Hospital

OTHER

NCT02338128 - The Cardiovascular Protective Effects of Febuxostat in Peritoneal Dialysis Patients | Biotech Hunter | Biotech Hunter